Holen Sie sich die Stockscreener-App
7.49
3.68%
0.29
Schlusskurs vom Vortag:
$7.20
Offen:
$7.2
24-Stunden-Volumen:
34,968
Relative Volume:
0.33
Marktkapitalisierung:
$48.17M
Einnahmen:
$5.75M
Nettoeinkommen (Verlust:
$-38.96M
KGV:
-0.6006
EPS:
-12.47
Netto-Cashflow:
$-32.63M
1W Leistung:
-3.05%
1M Leistung:
+27.61%
6M Leistung:
+0.34%
1J Leistung:
+26.42%
1-Tages-Spanne:
$7.20
$7.814
1-Wochen-Bereich:
$7.00
$7.92
52-Wochen-Spanne:
$2.92
$11.20
Kala Bio Inc Stock (KALA) Company Profile
Firmenname
Kala Bio Inc
Sektor
Branche
Telefon
781-996-5252
Adresse
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Vergleichen Sie KALA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
7.465 | 47.62M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
384.18 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.52 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.55 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
641.30 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
287.58 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-07-23 | Eingeleitet | Northland Capital | Outperform |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-05-27 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Kala Bio Inc Aktie (KALA) Neueste Nachrichten
Why KALA BIO Inc. stock attracts strong analyst attentionMachine Learning Stock Movement Detector - Newser
Technical analysis overview for KALA BIO Inc. stockPrice Movement and Market Sentiment Analysis - Newser
Using portfolio simulators with KALA BIO Inc. includedFree Swing Setup With Technical Confirmation - Newser
What makes KALA BIO Inc. stock price move sharplyFree Risk Managed Intraday Trade Alerts - Newser
Can volume confirm reversal in KALA BIO Inc.Free AI Screening for Swing Trade Picks - Newser
Is KALA BIO Inc. a Top Dividend Stock to Watch in 2025Profitable Trading Blueprint with Entry Zones - Newser
Trend analysis for KALA BIO Inc. this weekWeekly Trend Watch with Market Signals - Newser
How KALA BIO Inc. stock performs during market volatilityAccurate Forecast System with AI Support - Newser
What drives KALA BIO Inc.’s stock priceStocks with 300% Upside - sisaissue.com
KALA BIO Inc. stock trend forecastEntry Opportunity Screener with Confirmation - Newser
Comparing KALA BIO Inc. in custom built stock radarsWatchlist Generator With Real-Time Entry - Newser
KALA BIO: Q2 Earnings Snapshot - Greenwich Time
KALA BIO (NASDAQ:KALA) Stock Rating Lowered by Wall Street Zen - Defense World
Can KALA BIO Inc. recover in the next quarterFree Community Entry Consensus Trade Ideas - Newser
Momentum divergence signals in KALA BIO Inc. chartShort-Term Profit Alert With Entry Forecast - Newser
Kala Bio (KALA) Q2 Loss Widens 15% - AOL.com
KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biotech's Long Game: Assessing KALA BIO's Q2 Loss in the Context of Strategic Innovation - AInvest
Kala Bio (KALA) Q2 Loss Widens 15% - The Motley Fool
KALA BIO, Inc. Completes Patient Enrollment in Phase 2b CHASE Trial for KPI-012 in Persistent Corneal Epithelial Defect, Reports Financial Results and Upcoming Milestones - Quiver Quantitative
KALA BIO, Inc. SEC 10-Q Report - TradingView
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference | KALA Stock News - GuruFocus
KALA BIO, Inc. to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025 - Quiver Quantitative
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire
What candlestick patterns are forming on KALA BIO Inc.Machine Learning Stock Price Forecast Tool - Newser
KALA BIO Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDownside Risk Evaluation and Stock Analysis - Newser
What is the dividend policy of KALA BIO Inc. stockUnlock market-leading stock analysis - Jammu Links News
Should I hold or sell KALA BIO Inc. stock in 2025Capitalize on strategic market trends - Jammu Links News
How volatile is KALA BIO Inc. stock compared to the marketRapid growth opportunities - Jammu Links News
Is KALA BIO Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
What institutional investors are buying KALA BIO Inc. stockCapitalize on proven investment strategies - Jammu Links News
How does KALA BIO Inc. compare to its industry peersOutstanding capital returns - Jammu Links News
Is KALA BIO Inc. a growth stock or a value stockAchieve exceptional returns with expert guidance - Jammu Links News
What is the risk reward ratio of investing in KALA BIO Inc. stockGet professional guidance for market timing - Jammu Links News
Finanzdaten der Kala Bio Inc-Aktie (KALA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kala Bio Inc-Aktie (KALA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Jun 24 '25 |
Sale |
4.01 |
3,631 |
14,560 |
62,100 |
| Bazemore Todd | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
4,058 |
16,273 |
83,699 |
| Brazzell Romulus K | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
5,251 |
21,057 |
82,698 |
| Iwicki Mark T | Director |
Jun 24 '25 |
Sale |
4.01 |
13,227 |
53,040 |
258,433 |
0.90%
3.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):